What a screening measure can do
Screening is an initial process for identifying people who may benefit from further assessment; it is not the same task as establishing a diagnosis. [1][2]
- Collect responses consistently around a defined construct.
- Help a clinician notice patterns that merit follow-up.
- Support transparent triage or assessment workflows when the intended use is defined.
- Provide a baseline that may be compared cautiously with later use of the same measure.
Why a cut-off cannot make the diagnosis
Sensitivity and specificity describe performance under studied conditions, while the probability that a particular result is a true positive or true negative also depends on prevalence and the population being assessed. [1]
A threshold can help define a follow-up rule, but it cannot by itself resolve differential explanations, functional context, duration, impairment, comorbidity, response bias, or other evidence used in a fuller assessment. [3]
- False positives can occur, especially when a screened condition is uncommon in the tested population.
- False negatives can occur because no screening instrument has perfect sensitivity in every context.
- Scores near a threshold should not be treated as categorically different when measurement uncertainty and context are ignored.
From screening response to accountable review
A four-step path that keeps the calculated screening result separate from assessment and follow-up decisions.
- Collect
Use the intended version and administration method with clear respondent information.
- Calculate
Apply the defined scoring rule and retain version and completion context.
- Review
A named clinician considers the result with item-level and wider evidence.
- Decide
Record the next step separately without presenting the score as a diagnosis.
Interpret the result in context
Clinical review should consider why the measure was used, whether it was completed as intended, relevant item-level information, the person's circumstances, other available evidence, and the limitations stated by the measure developer. [3]
- Confirm the exact instrument, version, language, scoring method, and completion date.
- Review missing responses and any conditions that could affect completion.
- Ask whether the validation population and setting resemble the current use.
- Avoid interpreting score differences across non-equivalent versions or instruments as direct change.
Make follow-up part of the screening design
The USPSTF ties screening recommendations to systems that ensure appropriate evaluation, care, and follow-up, which makes the surrounding workflow part of safe implementation rather than an afterthought. [2]
- Name the clinician or team responsible for reviewing every completed result.
- Set expected review timing and an escalation path for responses that require prompt attention.
- Explain to respondents what the measure is for, who will see it, and when they should seek urgent help outside the workflow.
- Record the review and subsequent decision separately from the raw score.
Communicate scores without overclaiming
- Name the measure and date rather than using an unlabeled severity statement.
- State the intended use and material limitations in plain language.
- Distinguish the calculated result, the clinician's observations, and any subsequent conclusion.
- Avoid deterministic language such as confirms, proves, rules out, or guarantees unless a separate authoritative basis genuinely supports it.
Sources and further reading
- Screening programmes: a short guide (opens in a new tab)World Health Organization Regional Office for Europe. Published 2020. Accessed 2026-07-13. Official guide distinguishing screening from diagnosis and explaining programme-level benefits and harms.
- Depression and Suicide Risk in Adults: Screening (opens in a new tab)U.S. Preventive Services Task Force. Published 2023. Accessed 2026-07-13. Official recommendation emphasizing further evaluation and systems for follow-up after screening.
- Depression in adults: treatment and management (NG222) (opens in a new tab)National Institute for Health and Care Excellence. Published 2022. Accessed 2026-07-13. Official clinical guideline describing comprehensive assessment and the contextual use of validated measures.